Muhsin, Ma’an

Inserm · The University of Western Australia · Royal Perth Hospital · NYU Langone Health · Fondation pour l’innovation en Cadiométabolisme et Nutrition · McGill University · New York University · Université de Montréal · Icahn School of Medicine at Mount Sinai

2 papers on CoChatORCID 0009-0009-8623-5946

Most cited papers

Verified
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
Rosenson, R. S., Gaudet, D., Hegele, R. A., Ballantyne, C. M., Nicholls, S. J., Lucas, K. J., San Martin, J., Zhou, R., Muhsin, M., Chang, T., et al. (2024) · New England Journal of Medicine
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 213
Verified
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
Watts, G. F., Rosenson, R. S., Hegele, R. A., Goldberg, I. J., Gallo, A., Mertens, A., Baass, A., Zhou, R., Muhsin, M., Hellawell, J., et al. (2025) · New England Journal of Medicine
Lipid metabolism and disordersLipoproteins and Cardiovascular Health
Cited by 178

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free